ISR Share Price Performance
SEK 0
0.00 (0.00%)
Price SEK 0
Share Pricen/a
ISR Immune System Regulation Holding AB (publ) Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
ISR Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
ISR Immune System Regulation Holding AB (publ) Key Details
About ISR
- Founded
- 2007
- Employees
- 5
- CEO
- WebsiteView website
ISR Immune System Regulation Holding AB (publ) develops immunostimulatory drugs to treat chronic infectious diseases and cancer in Sweden. Its product pipeline includes Covid-19 vaccine, hepatitis B (HBV), human immunodeficiency virus (HIV), and oncology drugs. The company was founded in 2007 and is headquartered in Solna, Sweden.
